Angion Biomedica
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ANGN and buy or sell other stocks, ETFs, and their options commission-free!About ANGN
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes.
CEORobert T. Connelly
CEORobert T. Connelly
Employees32
Employees32
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2011
Founded2011
Employees32
Employees32
ANGN Key Statistics
Market cap206.07M
Market cap206.07M
Price-Earnings ratio-2.41
Price-Earnings ratio-2.41
Dividend yield—
Dividend yield—
Average volume113.59K
Average volume113.59K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$12.62
52 Week high$12.62
52 Week low$4.60
52 Week low$4.60
Stock Snapshot
With a market cap of 206.07M, Angion Biomedica(ANGN) trades at $11.94. The stock has a price-to-earnings ratio of -2.41.
Angion Biomedica(ANGN) stock opened on 2025-12-13 at —. The price climbed to — and dipped to —.
Angion Biomedica(ANGN) shares are trading with a volume of 0, against a daily average of 113.59K.
During the past year, Angion Biomedica(ANGN) stock moved between $4.60 at its lowest and $12.62 at its peak.
During the past year, Angion Biomedica(ANGN) stock moved between $4.60 at its lowest and $12.62 at its peak.
People also own
Based on the portfolios of people who own ANGN. This list is generated using Robinhood data, and it’s not a recommendation.